Market Overview:
The Global Microbubbles/Ultrasound Contrast Agents Market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing demand for ultrasound contrast agents in medical applications, rising prevalence of chronic diseases, and technological advancements in microbubble technology. However, the high cost of ultrasound contrast agents may restrain the market growth during the forecast period. Based on type, the global microbubbles/ultrasound contrast agents market is segmented into power ultrasound and detection of ultrasonic. The power ultrasound segment dominated the global microbubbles/ultrasound contrast agents market in 2017 and is projected to maintain its dominance during the forecast period. This can be attributed to its growing use in medical applications such as diagnosis and treatment of various diseases such as cancer, heart disease, liver cirrhosis, etc., owing to its ability to improve image quality by providing better visualization of tissues and organs under examination. Based on application, the global microbubbles/ultrasound contrast agents market is segmented into military & defense sector; medical sector (cardiology & radiology); industrial sector (manufacturing processes & quality control); research institutes; veterinary medicine; and other applications (agriculture).
Product Definition:
Microbubbles are small gas-filled bubbles that are used as ultrasound contrast agents. They are important because they can improve the image quality of ultrasound images and help to distinguish between tissues and organs.
Power Ultrasound:
Power ultrasound is a new technology that has been around for about 5 years. It was first commercialized by Bracco Imaging in the year 2010. The growth factor responsible for its early acceptance includes high performance, short exposure time (5ms), and real-time imaging offered by this technique over other conventional ultrasound techniques with longer exposure times (20-30ms).
Detection of Ultrasonic:
The detection of ultrasonic is the process of detecting and identifying the sound waves in an ultrasonic range. Ultrasound contrast agents are used to enhance ultrasound imaging by increasing the intensity or volume of echos that bounce off internal organs, bones, blood vessels and other tissues. The use of these agents depends on a number of factors such as body temperature, blood flow, tissue elasticity and viscosity among others.
Application Insights:
The medical application segment dominated the global market in terms of revenue in 2017. The growing usage of ultrasound for non-invasive imaging and diagnostics is expected to be a key factor driving the growth of this segment over the forecast period. Ultrasound contrast agents provide enhanced diagnostic information about organs & structures that are hard to see on conventional X-ray images, which is likely to propel their demand in medical applications.
Military was one of the prominent segments that accounted for a significant share in 2017 owing to extensive usage as an essential tool for enhancing situational awareness and troop performance across various theatres globally. Microbubbles enhance visibility by acting as a natural ultrasound emitter, which helps improve target identification during military training and combat operations at night or behind barriers where conventional lighting may not be available or appropriate.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing applications of ultrasound in different areas such as medical, industrial, and others. In addition, growing number of FDA approvals for microbubbles/ultrasound contrast agents is also one of the major factors contributing toward regional growth. For instance, Ultrasound Contrast AGNT (DuraGen) received U.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising healthcare expenditure and initiatives undertaken by governments across various countries including China & India & Australia are some factors that can be attributed towards this growth rate Other regions such as Latin America.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily owing to the increasing number of geriatric population and rising prevalence of lifestyle diseases such as obesity and diabetes. Microbubbles/ultrasound contrast agents are used during these procedures for better visualization of the surgical area, which is driving their demand.
- Rising incidence of cardiovascular diseases: Cardiovascular diseases are one of the leading causes of death globally, accounting for 31%of all deaths in 2012 according to World Health Organization (WHO). This number is expected to rise in coming years due to increasing aging population and changing lifestyles. Microbubbles/ultrasound contrast agents are used during cardiac procedures such as angiography and percutaneous coronary interventions (PCI) for better visualization, which is driving their demand in this segment.
Scope Of The Report
Report Attributes
Report Details
Report Title
Microbubbles/Ultrasound Contrast Agents Market Research Report
By Type
Power Ultrasound, Detection of Ultrasonic
By Application
Military, Medical, Industrial, Others
By Companies
Lantheus Holdings, Bracco, GE Healthcare, Daiichi Sankyo, NanoPET Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Microbubbles/Ultrasound Contrast Agents Market Report Segments:
The global Microbubbles/Ultrasound Contrast Agents market is segmented on the basis of:
Types
Power Ultrasound, Detection of Ultrasonic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Military, Medical, Industrial, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lantheus Holdings
- Bracco
- GE Healthcare
- Daiichi Sankyo
- NanoPET Pharma
Highlights of The Microbubbles/Ultrasound Contrast Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Power Ultrasound
- Detection of Ultrasonic
- By Application:
- Military
- Medical
- Industrial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Microbubbles/Ultrasound Contrast Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Microbubbles are small bubbles of gas that have a diameter of less than 100 nanometers. Ultrasound contrast agents are substances that increase the contrast between tissues in an image.
Some of the major companies in the microbubbles/ultrasound contrast agents market are Lantheus Holdings, Bracco, GE Healthcare, Daiichi Sankyo, NanoPET Pharma.
The microbubbles/ultrasound contrast agents market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microbubbles/Ultrasound Contrast Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Microbubbles/Ultrasound Contrast Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Microbubbles/Ultrasound Contrast Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Microbubbles/Ultrasound Contrast Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Microbubbles/Ultrasound Contrast Agents Market Size & Forecast, 2018-2028
4.5.1 Microbubbles/Ultrasound Contrast Agents Market Size and Y-o-Y Growth
4.5.2 Microbubbles/Ultrasound Contrast Agents Market Absolute $ Opportunity
Chapter 5 Global Microbubbles/Ultrasound Contrast Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
5.2.1 Power Ultrasound
5.2.2 Detection of Ultrasonic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Microbubbles/Ultrasound Contrast Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
6.2.1 Military
6.2.2 Medical
6.2.3 Industrial
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Microbubbles/Ultrasound Contrast Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Microbubbles/Ultrasound Contrast Agents Analysis and Forecast
9.1 Introduction
9.2 North America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
9.6.1 Power Ultrasound
9.6.2 Detection of Ultrasonic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
9.10.1 Military
9.10.2 Medical
9.10.3 Industrial
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Microbubbles/Ultrasound Contrast Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
10.6.1 Power Ultrasound
10.6.2 Detection of Ultrasonic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
10.10.1 Military
10.10.2 Medical
10.10.3 Industrial
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Microbubbles/Ultrasound Contrast Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
11.6.1 Power Ultrasound
11.6.2 Detection of Ultrasonic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
11.10.1 Military
11.10.2 Medical
11.10.3 Industrial
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Microbubbles/Ultrasound Contrast Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
12.6.1 Power Ultrasound
12.6.2 Detection of Ultrasonic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
12.10.1 Military
12.10.2 Medical
12.10.3 Industrial
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Microbubbles/Ultrasound Contrast Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Type
13.6.1 Power Ultrasound
13.6.2 Detection of Ultrasonic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Microbubbles/Ultrasound Contrast Agents Market Size Forecast by Applications
13.10.1 Military
13.10.2 Medical
13.10.3 Industrial
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Microbubbles/Ultrasound Contrast Agents Market: Competitive Dashboard
14.2 Global Microbubbles/Ultrasound Contrast Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lantheus Holdings
14.3.2 Bracco
14.3.3 GE Healthcare
14.3.4 Daiichi Sankyo
14.3.5 NanoPET Pharma
